NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In
Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational
UT Board Announces Support for MD Anderson Tenure System
Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals
In Brief: ESMO Names Annual Award Winners
Drugs and Targets: Akynzeo approved for chemotherapy-related nausea
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV
- “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor